As FDA weighs a ban on menthol in cigarettes, study shows how the tobacco industry targeted products to women, teens and Black people.
In breast and lung cancer patients with metastatic disease, seeds of metastasis were often planted before the primary tumor was diagnosed, a study finds.
The experts on Stanford Medicine's molecular tumor board brainstorm new ways to attack individual patients' tumors at the genetic level.
Stanford physician Lucy Kalanithi opens up about loss, grief and love for her neurosurgeon husband, Paul, five years after his death from lung cancer.
Stanford researchers are working on a test to identify early-stage lung cancer by detecting tumor-specific mutations in bits of DNA in the bloodstream.
Scientists create a new 3D lung cancer model to better reveal the drivers of cancer, and in doing so, find a new gene that may be a possible drug target.
Scientists at Stanford have developed a new PET scan tracer that flags both pancreatic cancer and a lung disease known as idiopathic pulmonary fibrosis.
When Stanford's James Spudich was diagnosed with lung cancer, one of his first thoughts was of his colleague, lung development expert Mark Krasnow. Within hours a group of Stanford scientists had launched an astoundingly comprehensive study of healthy and diseased human lung tissue from one of their own.
I've mentioned before how circulating tumor DNA, or ctDNA, is likely to be a valuable tool for predicting disease recurrence in patients with lymphoma. Now …
My father taught me to play chess when I was in grade school and I can recall many quiet evenings playing with him in the living room …
I've written here before about advances made by Stanford researchers in detecting and sequencing tumor DNA circulating in the blood of cancer patients. It's a revolutionary …
Earlier this month, football fans across the world watched as the New England Patriots shocked the Seattle Seahawks with a very dramatic last-minute win. While …
In a New York Times SundayReview piece, Paul Kalanithi, MD, a chief resident in neurological surgery at Stanford, describes cancer prognoses from two perspectives, both …
